182 related articles for article (PubMed ID: 35899343)
1. [Survival analysis of long-term HIV/AIDS cases aged 15 years and over under antiretroviral treatment in Henan Province from 2002 to 2020].
Yang WJ; Li J; Ma YM; Liu Y; Xuan SL; Li N
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jul; 56(7):919-925. PubMed ID: 35899343
[No Abstract] [Full Text] [Related]
2. [Analysis on mortality in HIV/AIDS cases aged 15 years and older under antiretroviral treatment in Henan province, 2002-2019].
Yang WJ; Liu Y; Li J; Ma YM; Li N
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Sep; 42(9):1594-1600. PubMed ID: 34814589
[No Abstract] [Full Text] [Related]
3. [Analysis on 10 year survival of HIV/AIDS patients receiving antiretroviral therapy during 2003-2005 in Henan province].
Sun Y; Zhao QX; Li CF; Yang X; Zhang X; Liu CL; Chen ZY
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jul; 39(7):966-970. PubMed ID: 30060313
[No Abstract] [Full Text] [Related]
4. [Survival analysis of AIDS patients of 15 years or above years old after initiation antiretroviral treatment in Henan province during 2005 to 2014].
Yang W; Fan P; Liang Y; Nie Y; Li N; Sun D; Zhu Q; Wang Z
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Dec; 49(12):1061-6. PubMed ID: 26887300
[TBL] [Abstract][Full Text] [Related]
5. [Survival analysis on HIV/AIDS cases newly received antiretroviral therapy who coinfected with hepatitis B virus in Jiangsu Province, 2005-2020].
Qiu T; Ding P; Zhang Z; Zhai XJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Feb; 45(2):220-224. PubMed ID: 38413060
[No Abstract] [Full Text] [Related]
6. [Survival analysis on Former Plasma Donors living with HIV/AIDS after initiation of antiretroviral therapy in Henan province, 2002-2017].
Liang Y; Yang WJ; Sun DY; Li N; Wang Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Jun; 40(6):638-642. PubMed ID: 31238611
[No Abstract] [Full Text] [Related]
7. [A retrospective cohort study on survival status of AIDS patients among 15 or above-year-olds in Henan province, from 2008 to 2015].
Yang WJ; Li N; Liang Y; Li J; Fan PY; Sun DY; Zhu Q; Wang Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):173-178. PubMed ID: 28231661
[No Abstract] [Full Text] [Related]
8. Suboptimal immune recovery and associated factors among people living with HIV/AIDS on second-line antiretroviral therapy in central China: A retrospective cohort study.
Zhu K; Xu Q; Ma Y; Li P; Jia H; Jiang Q; Wang Y; Wu Z; Wang D; Guo H; Jin Y
J Med Virol; 2022 Oct; 94(10):4975-4982. PubMed ID: 35710693
[TBL] [Abstract][Full Text] [Related]
9. [A retrospective cohort study of case fatality rate of HIV/AIDS cases and influencing factors in Jingzhou, Hubei Province, 1996-2021].
Lin MW; Pei YX; Chen QF; Liu R; Sun C; Dou ZH
Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Sep; 44(9):1369-1375. PubMed ID: 37743268
[No Abstract] [Full Text] [Related]
10. Outcomes and factors associated with survival of patients with HIV/AIDS initiating antiretroviral treatment in Liangshan Prefecture, southwest of China: A retrospective cohort study from 2005 to 2013.
Zhang G; Gong Y; Wang Q; Deng L; Zhang S; Liao Q; Yu G; Wang K; Wang J; Ye S; Liu Z
Medicine (Baltimore); 2016 Jul; 95(27):e3969. PubMed ID: 27399071
[TBL] [Abstract][Full Text] [Related]
11. [Survival time and associated factors of 8 310 AIDS patients initially receiving antiretroviral treatment of Liangshan Yi Autonomous Prefecture, Sichuan province of China].
Zhang G; Gong Y; Wang Q; Zhang S; Liao Q; Yu G; Wang K; Wang J; Ye S; Liu Z
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Nov; 49(11):967-72. PubMed ID: 26833006
[TBL] [Abstract][Full Text] [Related]
12. [Antiretroviral treatment discontinuation and its influencing factors among HIV-infected patients who initiated ART from 2012 to 2015 in Wenshan prefecture, Yunnan Province].
Hu XS; Zhao Y; Huang LL; Luo YX; Wu ZY
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Nov; 51(11):982-987. PubMed ID: 29136742
[No Abstract] [Full Text] [Related]
13. [Study on the situation of antiretroviral therapy against HIV/AIDS in Henan province based on the CD4+ T cells count and virus load].
Liu J; Cui WG; Sun GQ; Zhu XP; Tian SA; Sun DY; Yang WJ; Li N; Zhu Q; Wang Z
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Sep; 31(9):1013-6. PubMed ID: 21162867
[TBL] [Abstract][Full Text] [Related]
14. [An analysis of factors associated with timeliness of antiretroviral therapy initiation among newly diagnosed HIV/AIDS from 2010 to 2014 in China].
Tang HL; Xu J; Han J; Li J; Mao YR
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):711-717. PubMed ID: 28763920
[No Abstract] [Full Text] [Related]
15. [Survival time of HIV/AIDS death cases after antiretroviral therapy and related factors in Henan province, 2003-2015].
Chen ZY; Zhao QX; Li CF; Liu CL; Yang X; Zhang X; Sun Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1514-1517. PubMed ID: 29141340
[No Abstract] [Full Text] [Related]
16. Survival analysis of PLWHA undergoing combined antiretroviral therapy: exploring long-term prognosis and influencing factors.
Pu JF; Wu J
Front Public Health; 2024; 12():1327264. PubMed ID: 38454987
[TBL] [Abstract][Full Text] [Related]
17. [Survival analysis of the AIDS patients under 14 years of age and receiving antiretroviral treatment in Henan province from 2003 to 2014].
Sun D; Yang W; Ma Y; Wang Q; Liu J; Fan P; Li N; Zhu Q; Wang Z
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Aug; 49(8):700-4. PubMed ID: 26733028
[TBL] [Abstract][Full Text] [Related]
18. [Survival time of HIV/AIDS cases and influencing factors in Gansu province, 1997-2018].
Li J; Li H; Yu AL; Wang B; Wang XR
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1398-1402. PubMed ID: 31838811
[No Abstract] [Full Text] [Related]
19. [Mortality rate and influencing factors among index partners of HIV discordant couples in the context of antiretroviral therapy, Zhumadian, Henan province, 2008-2014].
Chen FF; Wang L; Jin SS; Xu F; Wang L
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):955-9. PubMed ID: 27453104
[TBL] [Abstract][Full Text] [Related]
20. [Survival analysis on HIV/AIDS patients who began receiving antiretroviral therapy from 2005 to 2015 in Tianjin].
Guo Y; Zhou N; Zhao FN; Liu ZQ; Li L; Yu MH
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Aug; 40(8):936-940. PubMed ID: 31484257
[No Abstract] [Full Text] [Related]
[Next] [New Search]
